255 related articles for article (PubMed ID: 31679692)
1. Pirfenidone attenuates the profibrotic contractile phenotype of differentiated human dermal myofibroblasts.
Wells AR; Leung KP
Biochem Biophys Res Commun; 2020 Jan; 521(3):646-651. PubMed ID: 31679692
[TBL] [Abstract][Full Text] [Related]
2. Pirfenidone reduces profibrotic responses in human dermal myofibroblasts, in vitro.
Hall CL; Wells AR; Leung KP
Lab Invest; 2018 May; 98(5):640-655. PubMed ID: 29497173
[TBL] [Abstract][Full Text] [Related]
3. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
[TBL] [Abstract][Full Text] [Related]
4. Effect of Pirfenidone on TGF-β1-Induced Myofibroblast Differentiation and Extracellular Matrix Homeostasis of Human Orbital Fibroblasts in Graves' Ophthalmopathy.
Wu SB; Hou TY; Kau HC; Tsai CC
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680057
[TBL] [Abstract][Full Text] [Related]
5. Regulation of fibrotic changes by the synergistic effects of cytokines, dimensionality and matrix: Towards the development of an in vitro human dermal hypertrophic scar model.
Chawla S; Ghosh S
Acta Biomater; 2018 Mar; 69():131-145. PubMed ID: 29330036
[TBL] [Abstract][Full Text] [Related]
6. Wnt4 negatively regulates the TGF-β1-induced human dermal fibroblast-to-myofibroblast transition via targeting Smad3 and ERK.
Liu J; Zhao B; Zhu H; Pan Q; Cai M; Bai X; Li X; Hu X; Zhang M; Shi J; Zheng Z; Yang A; Hu D
Cell Tissue Res; 2020 Mar; 379(3):537-548. PubMed ID: 31776823
[TBL] [Abstract][Full Text] [Related]
7. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
8. LY2109761 reduces TGF-β1-induced collagen production and contraction in hypertrophic scar fibroblasts.
Wei G; Xu Q; Liu L; Zhang H; Tan X; Zhang C; Han C; Guo Y; Han G; Zhang C
Arch Dermatol Res; 2018 Oct; 310(8):615-623. PubMed ID: 30046895
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow concentrate-induced mesenchymal stem cell conditioned medium facilitates wound healing and prevents hypertrophic scar formation in a rabbit ear model.
Hu CH; Tseng YW; Chiou CY; Lan KC; Chou CH; Tai CS; Huang HD; Hu CW; Liao KH; Chuang SS; Yang JY; Lee OK
Stem Cell Res Ther; 2019 Aug; 10(1):275. PubMed ID: 31462299
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic screening identifies hydroxypyridone anti-fungals as novel medicines for the prevention of hypertrophic scars.
Lapthorn AR; Ilg MM; Sullivan JV; Dziewulski P; Cellek S
Eur J Pharmacol; 2022 Dec; 937():175374. PubMed ID: 36343693
[TBL] [Abstract][Full Text] [Related]
11. Pirfenidone inhibits transforming growth factor β1-induced extracellular matrix production in nasal polyp-derived fibroblasts.
Shin JM; Park JH; Park IH; Lee HM
Am J Rhinol Allergy; 2015; 29(6):408-13. PubMed ID: 26637578
[TBL] [Abstract][Full Text] [Related]
12. miR-145 Contributes to Hypertrophic Scarring of the Skin by Inducing Myofibroblast Activity.
Gras C; Ratuszny D; Hadamitzky C; Zhang H; Blasczyk R; Figueiredo C
Mol Med; 2015 Apr; 21(1):296-304. PubMed ID: 25876136
[TBL] [Abstract][Full Text] [Related]
13. Suppression of TGF-β pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro.
Stahnke T; Kowtharapu BS; Stachs O; Schmitz KP; Wurm J; Wree A; Guthoff RF; Hovakimyan M
PLoS One; 2017; 12(2):e0172592. PubMed ID: 28231275
[TBL] [Abstract][Full Text] [Related]
14. Wnt/β-catenin pathway forms a negative feedback loop during TGF-β1 induced human normal skin fibroblast-to-myofibroblast transition.
Liu J; Wang Y; Pan Q; Su Y; Zhang Z; Han J; Zhu X; Tang C; Hu D
J Dermatol Sci; 2012 Jan; 65(1):38-49. PubMed ID: 22041457
[TBL] [Abstract][Full Text] [Related]
15. In vitro cultured fetal fibroblasts have myofibroblast-associated characteristics and produce a fibrotic-like environment upon stimulation with TGF-β1: Is there a thin line between fetal scarless healing and fibrosis?
Walraven M; Akershoek JJ; Beelen RH; Ulrich MM
Arch Dermatol Res; 2017 Mar; 309(2):111-121. PubMed ID: 28004279
[TBL] [Abstract][Full Text] [Related]
16. Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts.
Conte E; Gili E; Fagone E; Fruciano M; Iemmolo M; Vancheri C
Eur J Pharm Sci; 2014 Jul; 58():13-9. PubMed ID: 24613900
[TBL] [Abstract][Full Text] [Related]
17. Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring.
Crawford J; Nygard K; Gan BS; O'Gorman DB
Exp Dermatol; 2015 Feb; 24(2):120-6. PubMed ID: 25421393
[TBL] [Abstract][Full Text] [Related]
18. Effect of Keratinocytes on Myofibroblasts in Hypertrophic Scars.
Lee JS; Kim JS; Lee JW; Choi KY; Yang JD; Cho BC; Oh EJ; Kim TJ; Ko UH; Shin JH; Jeon S; Lee YJ; Chung HY
Aesthetic Plast Surg; 2019 Oct; 43(5):1371-1380. PubMed ID: 31346713
[TBL] [Abstract][Full Text] [Related]
19. Human xylosyltransferase-I - a new marker for myofibroblast differentiation in skin fibrosis.
Faust I; Roch C; Kuhn J; Prante C; Knabbe C; Hendig D
Biochem Biophys Res Commun; 2013 Jul; 436(3):449-54. PubMed ID: 23747722
[TBL] [Abstract][Full Text] [Related]
20. Halofuginone regulates keloid fibroblast fibrotic response to TGF-β induction.
Marty P; Chatelain B; Lihoreau T; Tissot M; Dirand Z; Humbert P; Senez C; Secomandi E; Isidoro C; Rolin G
Biomed Pharmacother; 2021 Mar; 135():111182. PubMed ID: 33433355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]